Literature DB >> 24581430

Advances in pediatric asthma in 2013: coordinating asthma care.

Stanley J Szefler1.   

Abstract

Last year's "Advances in pediatric asthma: moving toward asthma prevention" concluded that "We are well on our way to creating a pathway around wellness in asthma care and also to utilize new tools to predict the risk for asthma and take steps to not only prevent asthma exacerbations but also to prevent the early manifestations of the disease and thus prevent its evolution to severe asthma." This year's summary will focus on recent advances in pediatric asthma on prenatal and postnatal factors altering the natural history of asthma, assessment of asthma control, and new insights regarding potential therapeutic targets for altering the course of asthma in children, as indicated in Journal of Allergy and Clinical Immunology publications in 2013 and early 2014. Recent reports continue to shed light on methods to understand factors that influence the course of asthma, methods to assess and communicate levels of control, and new targets for intervention, as well as new immunomodulators. It will now be important to carefully assess risk factors for the development of asthma, as well as the risk for asthma exacerbations, and to improve the way we communicate this information in the health care system. This will allow parents, primary care physicians, specialists, and provider systems to more effectively intervene in altering the course of asthma and to further reduce asthma morbidity and mortality.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Airway remodeling; asthma; asthma control; asthma exacerbations; biomarkers; early intervention in asthma; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting β-adrenergic agonists; personalized medicine; severe asthma; therapeutics

Mesh:

Substances:

Year:  2014        PMID: 24581430      PMCID: PMC3969825          DOI: 10.1016/j.jaci.2014.01.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  97 in total

1.  Maternal distress and childhood wheeze: mechanisms and context.

Authors:  Anita L Kozyrskyj; Alicia N Pawlowski
Journal:  Am J Respir Crit Care Med       Date:  2013-06-01       Impact factor: 21.405

2.  Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.

Authors:  Maarten O Blanken; Maroeska M Rovers; Jorine M Molenaar; Pauline L Winkler-Seinstra; Adam Meijer; Jan L L Kimpen; Louis Bont
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

3.  Early-life wheezing and respiratory syncytial virus prevention.

Authors:  Robert F Lemanske
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

4.  The Pediatric Asthma Control and Communication Instrument asthma questionnaire: for use in diverse children of all ages.

Authors:  Sande O Okelo; Michelle N Eakin; Cecilia M Patino; Alvin P Teodoro; Andrew L Bilderback; Darcy A Thompson; Antonio Loiaza-Martinez; Cynthia S Rand; Shannon Thyne; Gregory B Diette; Kristin A Riekert
Journal:  J Allergy Clin Immunol       Date:  2013-02-21       Impact factor: 10.793

5.  Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America.

Authors:  Camila Alexandrina Figueiredo; Leila D Amorim; Neuza M Alcantara-Neves; Sheila M A Matos; Philip J Cooper; Laura C Rodrigues; Mauricio L Barreto
Journal:  J Allergy Clin Immunol       Date:  2013-02-14       Impact factor: 10.793

6.  Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?

Authors:  Avraham Beigelman; Tonya S King; David Mauger; Robert S Zeiger; Robert C Strunk; H William Kelly; Fernando D Martinez; Robert F Lemanske; Katherine Rivera-Spoljaric; Daniel J Jackson; Theresa Guilbert; Ronina Covar; Leonard B Bacharier
Journal:  J Allergy Clin Immunol       Date:  2013-03-14       Impact factor: 10.793

7.  Rhinovirus wheezing illness and genetic risk of childhood-onset asthma.

Authors:  Minal Calışkan; Yury A Bochkov; Eskil Kreiner-Møller; Klaus Bønnelykke; Michelle M Stein; Gaixin Du; Hans Bisgaard; Daniel J Jackson; James E Gern; Robert F Lemanske; Dan L Nicolae; Carole Ober
Journal:  N Engl J Med       Date:  2013-03-27       Impact factor: 91.245

8.  Disrupted prenatal maternal cortisol, maternal obesity, and childhood wheeze. Insights into prenatal programming.

Authors:  Rosalind J Wright; Kate Fisher; Yueh-Hsiu Mathilda Chiu; Robert O Wright; Rebecca Fein; Sheldon Cohen; Brent A Coull
Journal:  Am J Respir Crit Care Med       Date:  2013-06-01       Impact factor: 21.405

9.  Body mass index trajectory classes and incident asthma in childhood: results from 8 European Birth Cohorts--a Global Allergy and Asthma European Network initiative.

Authors:  Peter Rzehak; Alet H Wijga; Thomas Keil; Esben Eller; Carsten Bindslev-Jensen; Henriette A Smit; Joost Weyler; Sandra Dom; Jordi Sunyer; Michelle Mendez; Maties Torrent; Oriol Vall; Carl-Peter Bauer; Dietrich Berdel; Beate Schaaf; Chih-Mei Chen; Anna Bergström; Maria P Fantini; Monique Mommers; Ulrich Wahn; Susanne Lau; Joachim Heinrich
Journal:  J Allergy Clin Immunol       Date:  2013-02-10       Impact factor: 10.793

10.  Fraction of exhaled nitric oxide and wheezing phenotypes in preschool children.

Authors:  Mi-Ae Oh; Jung Yeon Shim; Young-Ho Jung; Ju-Hee Seo; Hyung Young Kim; Ji-Won Kwon; Byoung-Ju Kim; Hyo Bin Kim; Woo Kyung Kim; So-Yeon Lee; Gwang Cheon Jang; Dae Jin Song; Ha-Jung Kim; Yee-Jin Shin; Jung-Won Park; Sang-Heon Cho; Joo-Shil Lee; Soo-Jong Hong
Journal:  Pediatr Pulmonol       Date:  2012-11-05
View more
  8 in total

1.  Trends in racial disparities for asthma outcomes among children 0 to 17 years, 2001-2010.

Authors:  Lara J Akinbami; Jeanne E Moorman; Alan E Simon; Kenneth C Schoendorf
Journal:  J Allergy Clin Immunol       Date:  2014-08-01       Impact factor: 10.793

2.  Budesonide and Calcitriol Synergistically Inhibit Airway Remodeling in Asthmatic Mice.

Authors:  Jun Qian; Yaqin Xu; Zhiwei Yu
Journal:  Can Respir J       Date:  2018-05-02       Impact factor: 2.409

3.  Therapeutic effects of liver soothing pingchuan formula decoction on experimental asthma in BALB/c mice via regulation of nerve growth factor-tyrosine kinase A pathway.

Authors:  Xin-Guang Zhang; Zheng Xue; Yi-Tao Zhao; Li Bai; Fei Liu; Li-Qing Li; Jie Wu; Jing-Dong Zhou; Jian-Er Yu
Journal:  Mol Med Rep       Date:  2018-03-14       Impact factor: 2.952

Review 4.  Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.

Authors:  Sheng-Chieh Lin; Fang-Yi Cheng; Jun-Jen Liu; Yi-Ling Ye
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

5.  Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age.

Authors:  Minna Lukkarinen; Annamari Koistinen; Riitta Turunen; Pasi Lehtinen; Tytti Vuorinen; Tuomas Jartti
Journal:  J Allergy Clin Immunol       Date:  2017-03-25       Impact factor: 10.793

6.  Effect of high-dose sublingual immunotherapy on respiratory infections in children allergic to house dust mite.

Authors:  Salvatore Barberi; Giorgio Ciprandi; Elvira Verduci; Enza D'Auria; Piercarlo Poli; Benedetta Pietra; Cristoforo Incorvaia; Serena Buttafava; Franco Frati; Enrica Riva
Journal:  Asia Pac Allergy       Date:  2015-07-29

Review 7.  A systematic review of predictive models for asthma development in children.

Authors:  Gang Luo; Flory L Nkoy; Bryan L Stone; Darell Schmick; Michael D Johnson
Journal:  BMC Med Inform Decis Mak       Date:  2015-11-28       Impact factor: 2.796

8.  MicroRNA-335-5p alleviates inflammatory response, airway fibrosis, and autophagy in childhood asthma through targeted regulation of autophagy related 5.

Authors:  Qingbin Liang; Jingjing He; Qian Yang; Qinghua Zhang; Yingjun Xu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.